Pharmaceutical News

RSS

Higher antibiotic exposure linked to increased risk of Parkinson's disease

Higher exposure to commonly used oral antibiotics is linked to an increased risk of Parkinson's disease according to a recently published study by researchers form the Helsinki University Hospital, Finland.

22 Nov 2019

Decreasing inappropriate antibiotic use is key strategy to control drug resistance

Antibiotic resistance is a larger public health threat than most people realize. And, the Centers for Disease Control and Prevention reports about half of all antibiotics in outpatient settings are incorrectly prescribed.

22 Nov 2019

New targeted treatment for insomnia has fewer side effects

Insomnia is one of the most common sleep disorders, and is most commonly treated with hypnotics. However, hypnotics have motor and cognitive side effects.

22 Nov 2019

Software tool can predict how drugs can be combined to create effective treatments

With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict how current drugs--including unlikely candidates--can be combined in new ways to create more effective treatments.

22 Nov 2019

CU Anschutz to train students to prescribe buprenorphine products for opioid use disorder

As the nation struggles with a persistent epidemic of opioid addiction, the University of Colorado Anschutz Medical Campus is taking a critical step that will allow its graduates to better treat patients and save lives.

21 Nov 2019

Anti-epileptic drugs linked to increase in patients' risk of suicide

Three of the most common forms of anti-epileptic drugs in Denmark is associated with increase in patients' risk of suicide. However, the risk is low and should be seen in conjunction with the many beneficial effects of the medicines.

21 Nov 2019

Statin use may reduce risk of developing lethal prostate cancer

New research led by Queen's University Belfast has found that men who are on statins, medicine used to lower blood cholesterol, may have a reduced risk of developing a more lethal form of prostate cancer.

21 Nov 2019

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM. MimiVax LLC principals Robert Fenstermaker, MD, and Michael Ciesielski, PhD, have announced that the company, spun off from Roswell Park in 2012, has entered into a China-exclusive licensing agreement for SurVaxM with Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical Co. Ltd. based in Shanghai, China.

20 Nov 2019

New California law may expand use of HIV prevention drugs, with caveats

Kellen Willhite was 24 when he learned he'd been exposed to HIV. What followed was, as he describes it, a second trauma: trying to obtain the drugs that could save him before it was too late.

20 Nov 2019

New drug 'ubrogepant' may work for migraine

A new study published in the November 19, 2019 issue of JAMA shows that a newly developed small molecule drug called ubrogepant may successfully fight migraine at doses of 25 and 50 mg, with pain relief at 2 hours with both doses, while the most troublesome symptom of migraine was held off at 2 hours post-dose with the 50 mg dose. This may help millions of migraine patients to achieve pain relief and function better.

19 Nov 2019

Improving the efficiency of antiangiogenic and antifibrotic drug for treatment of lung cancer

The University of Barcelona and Hospital Clínic de Barcelona collaborate with Boehringer Ingelheim Inc. to improve the efficiency of nintedanib, an antiangiogenic and antifibrotic drug, for the treatment of lung cancer.

19 Nov 2019

Scientists develop new therapy for acute myeloid leukemia

Cold Spring Harbor Laboratory scientists, with chemists and cancer biologists from Dana-Farber Cancer Institute, have developed a new therapy that extended the survival of mice with acute myeloid leukemia.

19 Nov 2019

Ketamine can decrease alcohol consumption in men, reveal FSU researchers

Research from Florida State University is giving physicians a better understanding of ketamine, a potentially useful tool in treating depression that still has unanswered questions.

19 Nov 2019

Researchers propose a novel method to underscore the benefits of HPV vaccine

Health campaigns on social media aimed at increasing human papillomavirus (HPV) vaccination may see greater success, according to Drexel University researchers, if they inject a narrative into information-based posts.

19 Nov 2019

Cannabis cannot be used as a replacement drug for people with opioid use disorder

There has been interest in cannabis being used as a replacement drug for people with opioid use disorder, but research at McMaster University has found it doesn't work.

19 Nov 2019

Antibiotics face an existential crisis

Antibiotics are facing an existential crisis less than a century after their introduction. The bacteria-fighting drugs are becoming less effective as a result of their overuse in both humans and animals.

18 Nov 2019

New CDC report raises concern over growing threat of antibiotic resistance

In the US, antibiotic-resistant germs are making millions sick and killing tens of thousands, according to new CDC report.

18 Nov 2019

WHO announces two-year scheme to drive down the price of insulin

The World Health Organization plans to make insulin more affordable for the millions of people suffering from diabetes.

18 Nov 2019

Opioid dose tapering rates as much as six times higher than recommended

Stigma and safety fears have made daily dose tapering of opioid prescriptions more common. New research from UC Davis Health physicians, however, shows tapering can occur at rates as much as six times higher than recommended, putting patients at risk of withdrawal, uncontrolled pain or mental health crises.

18 Nov 2019

Study examines how drug promotion rules influence physician prescribing practices

Findings from a new study led by researchers at Dartmouth's Geisel School of Medicine and Harvard Medical School and published in the journal Circulation: Cardiovascular Quality and Outcomes, show that the way in which pharmaceutical companies are permitted to share information about their drugs can influence physician prescribing practices.

14 Nov 2019